Pulmonx continues to expect revenue for the full year 2024 to be in the range of $81M to $84M…The Company also continues to expect gross margin for the full year 2024 to fall within the range of 74% to 75%. Pulmonx now expects total operating expenses for the full year 2024 to fall within the range of $127M to $129 M, inclusive of approximately $25 million of non-cash stock-based compensation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUNG:
- Pulmonx Reports First Quarter 2024 Financial Results
- Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
- Pulmonx Welcomes Mehul Joshi as New CFO with Comprehensive Compensation Package
- Pulmonx appoints Mehul Joshi CFO
- Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
